Medtronic Investors Sue Over $3B Inflated Stock Buyback
Medtronic Inc. investors on Monday accused the medical device maker's directors of making misleading statements about their marketing of the company's bone growth-stimulating device for off-label uses and causing the company...To view the full article, register now.
Already a subscriber? Click here to view full article